Ataraxis AI Launches Ataraxis Breast NEO, a New AI Test Predicting Response to Neoadjuvant Therapy in Breast Cancer

Ataraxis AI announced Ataraxis Breast NEO, a new predictive test within its Ataraxis Breast platform designed to estimate the likelihood of pathologic complete response (pCR) following neoadjuvant therapy in patients with early-stage breast cancer.